Cephalon, Inc. et al v. Slayback Pharma Limited Liability Company
| Cephalon, Inc. and Eagle Pharmaceuticals, Inc. |
| Slayback Pharma Limited Liability Company |
| 1:2017cv01154 |
| August 16, 2017 |
| US District Court for the District of Delaware |
| Wilmington Office |
| New Castle |
| Gregory M. Sleet |
| Patent - Abbreviated New Drug Application |
| 35 U.S.C. ยง 271 |
| None |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
406
MEMORANDUM.. Signed by Judge Colm F. Connolly on 7/6/2020. (fms)
|
|
Filing
394
OPINION Signed by Judge Colm F. Connolly on 4/27/2020. (nmf)
|
|
Filing
287
MEMORANDUM ORDER granting 271 MOTION for Judgment on the Pleadings on Apotex's Twenty-Eighth Additional Defense Pursuant to Fed. R. Civ. P. 12(c) and 12(h) filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 8/1/2019. (nmf)
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
